WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

69 Polo-Kantola P, Erkkola R, Irjala K, Pullinen S,
Virtanen I, Polo O. Effect of short-term transdermal
estrogen replacement therapy on sleep: a
randomized, double-blind crossover trial in
postmenopausal women. Fertil Steril
1999;71(5):873–80.
70 Utian WH, Burry KA, Archer DF, Gallagher JC,
Boyett RL, Guy MP. Tachon GJ. Chadha-Boreham
HK, Bouvet AA. Efficacy and safety of low, standard,
and high dosages of an estradiol transdermal
system (Esclim) compared with placebo on vasomotor
symptoms in highly symptomatic
menopausal patients. The Esclim Study Group. Am
J Obstet Gynecol 1999;181(1):71–9.
71 Kornafel KL, March CM. Estradiol gel in the treatment
of menopausal symptoms: a placebo-controlled
double-blind case study of efficacy and
safety. South Med J 1992;85(3):270–3.
72 Dennerstein L, Burrows GD, Hyman G, Wood C.
Menopausal hot flushes: a double blind comparison
of placebo, ethinyl oestradiol and norgestrel. Br J
Obstet Gynaecol 1978;85(11):852–6.
73 Studd J, Pornel B, Marton I, Bringer J, Varin C,
Tsouderos Y, Christiansen C. Efficacy and acceptability
of intranasal 17 beta-oestradiol for
menopausal symptoms: randomised dose-response
study [published erratum appears in Lancet
1999;354:780]. Aerodiol Study Group. Lancet
1999;353(9164):1574–8.
74 Eriksen PS, Rasmussen H. Low-dose 17 beta-estradiol
vaginal tablets in the treatment of atrophic
vaginitis: a double-blind placebo controlled study.
Eur J Obstet Gynecol Reprod Biol
1992;44(2):137–44.
75 Dickerson J, Bressler R, Christian CD, Hermann HW.
Efficacy of estradiol vaginal cream in postmenopausal
women. Clin Pharmacol Ther
1979;26(4):502–7.
76 Campbell S, Whitehead M. Oestrogen therapy and the
menopausal syndrome. Clin Obstet Gynaecol
1977;4(1):31–47.
77 Thomson J, Oswald I. Effect of oestrogen on the
sleep, mood, and anxiety of menopausal women.
Br Med J 1977;2(6098):1317–9.
78 Loprinzi CL, Michalak JC, Quella SK, et al.
Megestrol acetate for the prevention of hot flashes.
N Engl J Med 1995;331(6):347–52.
62
79 Zichella L, Falaschi P, Fioretti P, et al. Effects of
different dopamine agonists and antagonists on
post-menopausal hot flushes. Maturitas
1986;8(3):229–37.
80 David A, Don R, Tajchner G, Weissglas L.
Veralipride: alternative antidopaminergic treatment
for menopausal symptoms. Am J Obstet Gynecol
1988;158(5):1107–15.
81 Melis GB, Gambacciani M, Cagnacci A, Paoletti AM,
Mais V, Fioretti P. Effects of the dopamine antagonist
veralipride on hot flushes and luteinizing hormone
secretion in postmenopausal women. Obstet
Gynecol 1988;72(5):688–92.
82 van Lith ND, Motke JC. Opipramol in the climacteric
syndrome. A double-blind, placebo-controlled trial.
Maturitas 1983;5(1):17–23.
83 Salmi T, Punnonen R. Clonidine in the treatment of
menopausal symptoms. Int J Gynaecol Obstet
1979;16(5):422–6.
84 Coope J, Williams S, Patterson JS. A study of the
effectiveness of propranolol in menopausal hot
flushes. Br J Obstet Gynaecol 1978;85(6):472–5.
85 Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B.
Does dong quai have estrogenic effects in postmenopausal
women? A double-blind, placebocontrolled
trial. Fertil Steril 1997;68(6):981–6.
86 Gottlieb N. Nonhormonal agents show promise
against hot flashes. J Natl Cancer Inst
2000;92(14):1118–20.
87 Avis NE, Kaufert PA, Lock M, McKinlay SM, Vass
K. The evolution of menopausal symptoms.
Bailleres Clin Endocrinol Metab 1993;7(1):17–32.
88 Murkies AL, Wilcox G, Davis SR. Clinical review 92:
Phytoestrogens. J Clin Endocrinol Metab
1998;83(2):297–303.
89 Coward L, Setchell K, Barnes S. The antitumor
isoflavones, genistein and daidzein, in soybean
foods of American and Asian diets. J Agric Biol
Chem 1993;41:1961–7.
90 Murkies AL, Lombard C, Strauss BJ, Wilcox G,
Burger HG, Morton MS. Dietary flour supplementation
decreases post-menopausal hot flushes:
effect of soy and wheat. Maturitas
1995;21(3):189–95.
91 Brezezinski A, Aldercreutz H, Shoul R. Short-term
effects of phytoestrogen-rich diet on postmenopausal
women. Menopause 1997;4:89–94.